Understand the source comparison
Can You Stack Cerebrolysin with Other Peptides: Comparison
MK 677 Ghrelin receptor agonist (GH/IGF-1) Yes Evening dose, 8+ hours after Cerebrolysin Synergistic. GH elevation enhances BDNF receptor sensitivity without pathway overlap Thymalin Thymus peptide receptors (immune modulation) Alternate days or separate injec
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- MK 677
- Ghrelin receptor agonist (GH/IGF-1)
- Yes
- Evening dose, 8+ hours after Cerebrolysin
- Synergistic. GH elevation enhances BDNF receptor sensitivity without pathway overlap
- Thymalin
- Thymus peptide receptors (immune modulation)
- Alternate days or separate injection window
- No receptor conflict. Immune and neurotrophic pathways are orthogonal
- CJC-1295/Ipamorelin
- GHRH receptor/ghrelin mimetic (GH pulse)
- Evening injection, 8+ hours after Cerebrolysin
- Complementary. GH pulse timing avoids Cerebrolysin plasma peak
- Dihexa
- HGF/Met pathway (overlaps BDNF signalling)
- No. Receptor competition likely
- Not recommended for concurrent use
- Redundant. Both target synaptic plasticity through overlapping transcription factors
- P21
- CNTF-derived neurotrophin activity
- No. Same receptor class as Cerebrolysin
- Competitive inhibition risk. Saturates neurotrophin receptors without added benefit